DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY)
CUSIP: 256135203
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / American depositary shares, each representing one equity share
- Shares outstanding
- 834,731,296
- Total 13F shares
- 21,751,667
- Share change
- -1,012,319
- Total reported value
- $816,953,752
- Put/Call ratio
- 364%
- Price per share
- $37.56
- Number of holders
- 116
- Value change
- -$37,479,890
- Number of buys
- 37
- Number of sells
- 59
Quarterly Holders Quick Answers
What is CUSIP 256135203?
CUSIP 256135203 identifies RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 256135203:
Top shareholders of RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Fisher Asset Management, LLC |
13F
|
Company |
0.66%
|
5,468,292
|
$195,109,000 | — | 30 Sep 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.43%
|
3,613,913
|
$128,944,000 | — | 30 Sep 2017 | |
| COMMONWEALTH BANK OF AUSTRALIA |
13F
|
Company |
0.25%
|
2,106,822
|
$75,164,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
1,476,858
|
$52,694,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.18%
|
1,475,839
|
$52,658,000 | — | 30 Sep 2017 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
892,618
|
$31,849,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
655,284
|
$23,381,000 | — | 30 Sep 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.07%
|
581,938
|
$20,769,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
465,190
|
$16,596,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
431,631
|
$15,400,000 | — | 30 Sep 2017 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.05%
|
411,790
|
$14,693,000 | — | 30 Sep 2017 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.04%
|
355,987
|
$12,701,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
297,276
|
$10,678,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
270,451
|
$9,651,000 | — | 30 Sep 2017 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0.03%
|
264,692
|
$9,444,000 | — | 30 Sep 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.03%
|
234,396
|
$8,364,000 | — | 30 Sep 2017 | |
| STRS OHIO |
13F
|
Company |
0.03%
|
224,000
|
$7,992,000 | — | 30 Sep 2017 | |
| Dalton Investments, Inc. |
13F
|
Company |
0.02%
|
207,000
|
$7,386,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
184,073
|
$6,567,000 | — | 30 Sep 2017 | |
| Aperio Group, LLC |
13F
|
Company |
0.02%
|
181,974
|
$6,493,000 | — | 30 Sep 2017 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.02%
|
153,227
|
$5,467,000 | — | 30 Sep 2017 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.02%
|
134,916
|
$4,814,000 | — | 30 Sep 2017 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
134,664
|
$4,805,000 | — | 30 Sep 2017 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.02%
|
130,361
|
$4,651,000 | — | 30 Sep 2017 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.01%
|
110,141
|
$3,929,000 | — | 30 Sep 2017 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.01%
|
106,300
|
$3,793,000 | — | 30 Sep 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
105,375
|
$3,759,000 | — | 30 Sep 2017 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
104,899
|
$3,743,000 | — | 30 Sep 2017 | |
| Swiss National Bank |
13F
|
Company |
0.01%
|
104,162
|
$3,717,000 | — | 30 Sep 2017 | |
| AVIVA PLC |
13F
|
Company |
0.01%
|
102,311
|
$3,650,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
101,800
|
$3,632,000 | — | 30 Sep 2017 | |
| State of New Jersey Common Pension Fund D |
13F
|
Company |
0.01%
|
98,640
|
$3,519,000 | — | 30 Sep 2017 | |
| CAUSEWAY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
96,043
|
$3,427,000 | — | 30 Sep 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
92,297
|
$3,293,000 | — | 30 Sep 2017 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
74,364
|
$2,653,307 | — | 30 Sep 2017 | |
| Hexavest Inc. |
13F
|
Company |
0.01%
|
74,032
|
$2,641,000 | — | 30 Sep 2017 | |
| Portland Hill Asset Management Ltd |
13F
|
Company |
0.01%
|
57,192
|
$2,041,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
56,794
|
$2,026,000 | — | 30 Sep 2017 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
56,736
|
$2,024,000 | — | 30 Sep 2017 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.01%
|
56,620
|
$2,020,000 | — | 30 Sep 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
54,761
|
$1,954,000 | — | 30 Sep 2017 | |
| Sivik Global Healthcare LLC |
13F
|
Company |
0.01%
|
50,000
|
$1,784,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
48,705
|
$1,721,000 | — | 30 Sep 2017 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
45,796
|
$1,634,000 | — | 30 Sep 2017 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0%
|
40,350
|
$1,435,000 | — | 30 Sep 2017 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0%
|
34,900
|
$1,245,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0%
|
33,794
|
$1,206,000 | — | 30 Sep 2017 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
32,791
|
$1,170,000 | — | 30 Sep 2017 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0%
|
30,000
|
$1,071,000 | — | 30 Sep 2017 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0%
|
28,804
|
$1,028,000 | — | 30 Sep 2017 |
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2017
As of 31 Dec 2017,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,751,667 shares.
The largest 10 holders included
Fisher Asset Management, LLC, ROYAL BANK OF CANADA, Commonwealth Bank of Australia, BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, Mondrian Investment Partners LTD, and DEUTSCHE BANK AG\.
This page lists
116
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
116
Q4 2017 holders
116
Holder diff
0
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.